Practical Implementation: Protocol Development

Model-based designs such as continual reassessment method (CRM) can be used in settings where the acceptable dose-limiting toxicity (DLT) rate/threshold varies, as this is a design-tuning parameter and it can be specifically set to each protocol or type of drug. A review of model-based dose-escalati... View More